NEW YORK (GenomeWeb News) – OncoMethylome Sciences said today it will develop DNA methylation biomarkers for GlaxoSmithKline Biologicals that the drugmaker will use in its cancer immunotherapy program. 
 
The Belgian company will test its portfolio of methylation markers on clinical samples from GSK Biologicals, said OncoMethylome’s CTO, Jim DiGuiseppi.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.